Lanean...
Efficacy and tolerability of bortezomib and dexamethasone in newly diagnosed multiple myeloma
BACKGROUND: Outcome in multiple myeloma (MM) has improved substantially over recent years as a result of the availability of multiple novel agents with acceptable safety profile. STUDY DESIGN: Prospective observational study at a tertiary care institute. METHODS: Twenty-five newly diagnosed patients...
Gorde:
| Argitaratua izan da: | South Asian J Cancer |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Medknow Publications & Media Pvt Ltd
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5865101/ https://ncbi.nlm.nih.gov/pubmed/29600238 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/sajc.sajc_59_17 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|